|
0
|
|
CLIM-TIME links genetic cancer drivers to immune landscapes.
(linkinghub.elsevier.com)
|
Zhu L
…
Wang C
Cell
2026-03-05
|
#immunity
#cancer
#screening
#immunotherapy
#crispr
|
|
0
|
|
CLIM-TIME identifies metastatic microenvironment modulators for T cell therapy response.
(linkinghub.elsevier.com)
|
Wang Y
…
Wang G
Cell
2026-03-05
|
#transcriptomics
#immunotherapy
#crispr
#metastasis
#microenvironment
|
|
0
|
|
Persistent T cell activation and cytotoxicity against glioblastoma following single oncolytic virus treatment in a clinical trial.
(linkinghub.elsevier.com)
|
Meylan M
…
Wucherpfennig KW
Cell
2026-03-05
|
#immunotherapy
#cytotoxicity
#t cell
#glioblastoma
#oncolytic virus
|
|
0
|
|
Neoadjuvant GOLP in Resectable High-Risk Intrahepatic Cholangiocarcinoma.
(nejm.org)
|
Shi GM
…
Fan J
New England Journal of Medicine
2026-03-05
|
#cancer
#immunotherapy
#chemotherapy
#neoadjuvant
#cholangiocarcinoma
|
|
0
|
|
Targeting amyloid-beta pathology by chimeric antigen receptor astrocyte (CAR-A) therapy.
(science.org)
|
Chen Y
…
Colonna M
Science
2026-03-05
|
#transcriptomics
#immunotherapy
#neurodegeneration
#amyloid
|
|
0
|
|
Meningeal blood vessel blockage enhances anti-glioblastoma immunity.
(linkinghub.elsevier.com)
|
Gao Y
…
Zhang N
Cell
2026-03-05
|
#immunity
#immunotherapy
#cns
#macrophage
#glioblastoma
|